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Abstract
Current methods to derive induced pluripotent stem cell (iPSC) lines from human dermal fibroblasts by viral infection rely
on expensive and lengthy protocols. One major factor contributing to the time required to derive lines is the ability of
researchers to identify fully reprogrammed unique candidate clones from a mixed cell population containing transformed or
partially reprogrammed cells and fibroblasts at an early time point post infection. Failure to select high quality colonies early
in the derivation process results in cell lines that require increased maintenance and unreliable experimental outcomes.
Here, we describe an improved method for the derivation of iPSC lines using fluorescence activated cell sorting (FACS) to
isolate single cells expressing the cell surface marker signature CD13NEGSSEA4POSTra-1-60POS on day 7–10 after infection.
This technique prospectively isolates fully reprogrammed iPSCs, and depletes both parental and ‘‘contaminating’’ partially
reprogrammed fibroblasts, thereby substantially reducing the time and reagents required to generate iPSC lines without the
use of defined small molecule cocktails. FACS derived iPSC lines express common markers of pluripotency, and possess
spontaneous differentiation potential in vitro and in vivo. To demonstrate the suitability of FACS for high-throughput iPSC
generation, we derived 228 individual iPSC lines using either integrating (retroviral) or non- integrating (Sendai virus)
reprogramming vectors and performed extensive characterization on a subset of those lines. The iPSC lines used in this
study were derived from 76 unique samples from a variety of tissue sources, including fresh or frozen fibroblasts generated
from biopsies harvested from healthy or disease patients.
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Introduction
The discovery that differentiated somatic cells could be
reprogrammed to an embryonic stem cell-like state by forced
expression of four transcription factors (Oct4, Klf4, Sox2, cMyc)
has revolutionized the stem cell field [1]. Reprogrammed, or
induced pluripotent stem cells (iPSCs), show remarkable similar-
ities to embryonic stem cells (ESCs) and hold great promise for
in vitro disease modeling, drug discovery, and therapeutic inter-
ventions because they provide a potentially unlimited source of
differentiated cells from individuals with specific diseases
[2,3,4,5,6].
However, initial derivation of stable iPSC clones by viral
transduction of dermal fibroblasts is a slow (4–6 weeks) and
inefficient (#0.01% of total fibroblasts) process. Current methods
of identifying colonies of bona fide iPSCs early in the reprogram-
ming process (2–3 weeks post-infection) utilize light microscopy
and manual isolation of candidate colonies, which requires
training and expertise in advanced cell culture techniques. To
enable future clinical applications requiring de novo iPSC deriva-
tion, there remains a need for standardized and validated methods
for identifying, isolating and purifying reprogrammed cells.
Previous imaging studies based on tracking of cell-of-origin
suggest that early events occur during defined factor reprogram-
ming, including a change in cell proliferation rates and morphol-
ogy [7], downregulation of CD13, a marker of mesenchymal cells
including fibroblasts [8], as well as upregulation of the cell surface
markers of pluripotency SSEA4 and TRA-1-60 [9]. These studies
demonstrate that both partially and fully reprogrammed iPSCs
can be identified by combined use of surface expression of multiple
markers. Recently, a method of enriching reprogrammed fibro-
blasts by fluorescence activated cell sorting (FACS) for cells with
dual expression of the pluripotency surface markers SSEA4 and
TRA-1-81 arising late during reprogramming was described [10].
While a step forward, this method relies heavily on the use of a
defined small molecule cocktail, and multiple rounds of sorting
and extensive screening to identify fully reprogrammed clones.
This suggests that pluripotency markers alone are not sufficient to
purify fully reprogrammed iPSCs. Additionally, it is likely that the
high variability among clones seen within this population is
compounded by the use of integrating vectors to deliver the
reprogramming factors. Here, we confirm that throughout the
reprogramming process a significant proportion of SSEA4POSTra-
1-60POS cells retain the fibroblast surface marker, CD13. Through
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the use of negative selection against CD13, we were able to purify
fully reprogrammed iPSCs from partially reprogrammed cells and
parental fibroblasts by FACS. This method removes contaminat-
ing cells at an early stage and can be used with a variety of cell
populations including: cells reprogrammed with DNA-integrating
or non-integrating viruses; fibroblasts harvested from healthy or
specific disease patients. Using this method we have generated and
characterized 228 iPSC lines from 76 fibroblast lines obtained




The 0819 and 0825 foreskin fibroblast lines were provided from
the Skin Disease Research Center Core at Columbia University
under notice of institutional review board (IRB) exemption
(Columbia University) as no interaction with subjects and no
identifiable information were made available to researchers. The
1018 fibroblast line was derived from an upper arm skin biopsy
from a 32-year-old female with type I diabetes, diagnosed at age
10. The 1023 fibroblast line was derived from an upper arm skin
biopsy from a healthy 23-year-old male. Protocols for obtaining
the 1018 and 1023 skin biopsies and their use in reprogramming
were approved by the IRB and stem cell research oversight
(SCRO) committee of Columbia University and subjects provided
signed informed consent [11]. Fibroblast line 10001.131.01(131)
was obtained from a skin biopsy harvested from the left temple of a
61-year-old female. Protocols for obtaining the 10001.131.01 skin
biopsies and their use in reprogramming were reviewed and
approved by the Western Institutional Review Board (WIRB) and
subjects provided signed informed consent.
All cell lines summarized in Table S6 were obtained under
signed informed consent or are exempt as they were obtained from
a Coriell cell repository (http://www.ccr.coriell.org) and no
patient contact was made. The approval agency and IRB protocol
numbers are as follows: Alzheimer and FTD (Exempt Coriell);
Parkinsons; (WIRB NYSCF 10-0001); GAN (AAAE9976 Colum-
bia University); Cardiac LMNA and LongQT (AAA-
D5685(Y2M00) Columbia University);MODY, T1D, and T2D
(AAAD2280 Columbia University); MS_RR(NYSCF 10-005
WIRB ); MS_SP(NYSCF 10-001 WIRB ); healthy control lines
were obtained under all protocols listed above.
All mouse studies were reviewed and approved by the
institutional animal care and use committee (IACUC) of Columbia
University (Protocol Approval Number: AAAD8809). All proce-
dures were performed under anesthesia using 1–5% isofluorane,
and all efforts were made to minimize suffering.
Fibroblast Cell Culture
Explants of 3-mm dermal biopsies were minced and placed in a
60-mm tissue culture dish under a sterile coverslip held down by
sterilized silicon grease. Fibroblast medium [Dulbecco’s modified
Eagle’s medium (DMEM), supplemented with 10% fetal bovine
serum, GlutamaxTM, and penicillin/streptomycin (Invitrogen,
Carlsbad, CA)] was added, and dishes incubated at 37uC in a
humidified 5% CO2 atmosphere with media exchange every 5
days. Fibroblast outgrowths were harvested by trypsinization,
expanded in a T25 flask in fibroblast medium, and allowed to
reach ,90% confluence prior to freezing or splitting for
reprogramming as described below. For reprogramming, fibro-
blasts were used within the first three passages from biopsy or
within one passage after a thawing. All parent fibroblast and
reprogrammed lines were subjected to cytogenetic analysis (Cell
Line Genetics) and for DNA fingerprinting by short tandem repeat
(STR) analysis.
Fibroblast Reprogramming
Fibroblasts were reprogrammed using high titer stocks of
vesicular stomatitis virus G (VSVG)-coated retroviruses containing
Oct4, Sox2, cMyc, and Klf4 (Harvard Gene Therapy Initiative at
Harvard Medical School) as previously described [12], or the non-
integrating CytoTuneTM - Sendai viral vector kit (Life Technol-
ogies, A13780). Fibroblasts reprogrammed with retroviruses were
infected at 16104 cells/well in 1 ml of human ESC medium
(HUESM) [KnockoutTM DMEM supplemented with 20% Knock-
outTM serum replacement (Invitrogen), 10 ng/ml bFGF (Invitro-
gen), nonessential amino acids (Invitrogen), b-mercaptoethanol
(Invitrogen), L-glutamine, and penicillin/streptomycin (Invitro-
gen)]. The medium was exchanged on day 2 to HUESM
containing ALK5 inhibitor SB431542 (2 mM; Stemgent), MEK
inhibitor PD0325901 (0.5 mM; Stemgent), and ROCK inhibitor
[13] Thiazovivin (0.5 mM; Stemgent)] and changed daily there-
after. For Sendai virus mediated reprogramming, 56105 fibro-
blasts were infected in fibroblast medium at a multiplicity of
infection of 3 (MOI3) for two days with daily (HUESM) media
exchanges. At day 7–10 days post-infection by retro or Sendai
viral protocols, cells were subjected to FACS analysis or passaged
onto feeder cells by enzymatic dissociation using Dispase (GIBCO)
and/or Accutase (Sigma-Aldrich) then passaged onto c-irradiated
murine embryonic fibroblasts (MEFs; Globalstem) or MatrigelTM
(BD Biosciences) coated plates in HUESM at 26103 cells/cm2.
Fluorescent Activated Cell Sorting of Reprogrammed
Fibroblasts
Cells enzymatically harvested as described above were filtered
through a 35 mm cell strainer (BD biosciences) to obtain a single
cell suspension prior to resuspension in 100 ml of a sterile iPSC
staining buffer [DPBS containing 0.5% bovine serum albumin
fraction V (BSA; Invitrogen), 100 U/ml penicillin/streptomycin
(Invitrogen), 2 mM EDTA (Invitrogen), and 20 mM glucose
(Sigma)]. A cocktail of fluorescence-conjugated antibodies [1 ml
each anti-CD13 (555394) anti-SSEA4 (560219) and anti-Tra-1-60
(560173), obtained from BD, CA] was added to the cells and
incubated at room temperature (RT) for 15 minutes shielded from
light. Stained cells were washed once with iPSC staining buffer
and sorted immediately on a 5 laser BD Biosciences ARIA-IIuTM
SOU Cell Sorter using ‘‘gentle FACS’’ sorting conditions based on
the work of Pruszak et al. (100 mm ceramic nozzle, 20 psi) [14].
Some experiments included antibodies against SSEA3 (BD,
560237), or CD326 (BD, 347200) in the cocktail to confirm the
pluripotent status of the reprogrammed cells. Target cell
populations were sorted directly onto MEF layers (ARIA plate
holder at 37uC) at between 26103 and 56104 cells/well in a 6-well
plate containing HUESM plus 20 mM Y-27632 (ROCK inhibitor;
Calbiochem). Two days after sorting, the ROCK inhibitor was
removed from the medium and replaced with SB431542 (2 mM),
PD0325901 (0.5 mM), and Thiazovivin (0.5 mM) [13] with daily
media exchange. Several individual colonies were picked 7–10
days after sorting and expanded for characterization.
Quantitative RT-PCR
Total RNA was isolated from duplicate or triplicate cell samples
using the RNeasy kit (QIAGEN, 74136). cDNA synthesis was
performed on 1 mg RNA with SuperScriptTM III First-Strand
system (Invitrogen 18080-051) and oligo(dT) primers. The cDNA
was diluted to a final volume of 200 ml and 1 ml was added to
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Figure 1. Enhanced derivation and maintenance of virally reprogrammed fibroblasts using Fluorescence Activated Cell Sorting. (A)
CD13NEGSSEA4POSTra-1-60NEG and CD13NEGSSEA4POSTra-1-60POS populations from the manually derived 1018 clone were sorted onto MEF feeder
layers and expanded for 20 days prior to reanalysis by flow cytometry to assess retention of sorted surface markers. dpi = days post infection.
dps = days post sort. (B) CD13NEGSSEA4POS and CD13NEGSSEA4POSTra-1-60POS populations were sorted onto MEF layers at seven days post infection
and imaged at 3 and 17 dps to assess colony formation. (C) Colony counts arising from the sorted cell populations shown in Panel B at 17 dps
(25 dpi). (D) Gating structure used in the analysis of CD13POS cells present within the SSEA4POSTra-1-60POS population at 7 dpi. (E) Fluorescence
microscopy demonstrating NANOG expression in CD13POS cell at 7 dpi. 406magnification. CD13 shown in red. Nanog in shown Green. Values
designated %T indicates proportion of total cells within the culture positive for the indicated combinations of surface markers. Values without T
designation indicate the proportion of CD13NEGSSEA4POS cells that are Tra-1-60POS or Tra-1-60NEG in Panel A and D.
doi:10.1371/journal.pone.0059867.g001
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Figure 2. Fibroblasts undergoing viral reprogramming exhibit characteristic expression levels of surface markers at early time
points post infection. (A) Foreskin (0825) and adult dermal fibroblast (1018 and 1023) lines underwent four factor retroviral reprogramming and
were analyzed by flow cytometry for the emergence of the CD13NEGSSEA4POSTra-1-60POS population at seven day intervals post infection. Values
designated %T indicates proportion of total cells within the culture positive for the indicated combinations of surface markers. Values without T
designation indicate the proportion of cells positive within the parent gate. (B) Gating structure used to sort the CD13NEGSSEA4POSTra-1-60POS
populations for all cell lines derived in this study. Live cell are first defined using forward (FSC) and Side (SSC) light scattering properties. The
CD13NEGSSEA4POS population is then selected from the live cell gate (blue cells). The highest Tra-1-60POS expressing cells are then selected from the
CD13NEGSSEA4POS population (Green cells) and sorted for expansion and characterization. (C) Comparison of SSEA4POSTra-1-60POS populations
present in Retro (R) or Sendai (S) viral infected fibroblast cultures during first two weeks of programming. (D) Comparison of CD13POS cells present
within the SSEA4POSTra-1-60POS populations during first two weeks of programming following Retro (R) or Sendai (S) infection. Dpi 1–7:(R) n = 29, (S)
n = 21. Dpi 8–14: (R) n = 32, (S) n = 46. Total n = 228. Statistical significance was assessed via Student’s t-Test. * p,=0.05, ** p,=0.001, *** p,=0.001,
****p,= 0.0001.
doi:10.1371/journal.pone.0059867.g002
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Figure 3. Fluorescence Activated Cell Sorting generates higher quality independent clones than manual derivation. Modified
pluripotent scorecard assay was performed on manually and FACS derived clones to demonstrate (A) activation of endogenous gene expression and
(B) silencing of gene expression and presence of unreprogrammed and transformed fibroblasts CD13POS in manually derived clones. (C) Three sorted
and three picked lines from patient 1023 were used to compare the ability of both methods to generate independent clones. 10 m of genomic DNA
were cut overnight with BglII and submitted to Southern blotting. The HUES line HES2 was used as a positive control for endogenous KLF4/OCT4, and
as a negative control for transgene insertions. Samples were first blotted for KLF4, then stripped and reblotted for OCT4. Picked clones 1023 C and E
are consistent with being the same clone by both KLF4 and OCT4 blotting. * indicated the predicted endogenous KLF4/OCT4 bands, and ** indicated
a consistent band found in all samples blotted with OCT4.
doi:10.1371/journal.pone.0059867.g003
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500 nM of the forward and reverse primers in a final volume of
10 ml per PCR reaction. Quantitative real-time PCR was
performed using the GoTaqH SYBR Green Master kit (Promega,
A6001) and Mx3000p QPCR system (Stratagene). Primer
sequences are provided in Table S1.
Southern Blotting
Probes for human Oct4, Sox2, and KLF4 were generated by
PCR using the digoxigenin (DIG) probe synthesis kit (Roche) and
Southern blotting was performed using DIG System detection
reagents (Roche). Genomic DNA was isolated from human ESCs,
parent fibroblast cells, and iPSCs using the Qiagen DNA Mini kit.
DNA samples (5–10 mg) were digested overnight with BglII to
generate a single cut in the integrated viral backbone of each
transgene, and digests were resolved on a 0.8% agarose gel
(without ethidium bromide), which was then denatured with 0.5%
NaOH and neutralized. The gel was transferred to a nylon
membrane by overnight capillary transfer. Wet membranes were
crosslinked with 120 mJ UV (HL-2000 Hybrilinker, UVP) and
allowed to dry. Membranes were pre-hybridized with DIG Easy
Figure 4. hIPSC lines derived by Fluorescence Activated Cell Sorting possess in vitro and in vivo spontaneous differential potential.
Embryoid bodies were derived from FACS (A) or manually derived clones (B) and stained for expression of alpha fetoprotein, smooth muscle actin
and beta III tubulin (Tuj1) to demonstrate differentiation potential in vitro potential. 106Magnification (C) Differentiation potential of the derived
lines for expression of germ layer genes present in the Lineage scorecard assay. (D) Teratomas from FACS (D) or manually derived (E) clones of 1023
fibroblast line indicating in vitro differentiation potential by formation of three germ layers.
doi:10.1371/journal.pone.0059867.g004
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Hyb buffer for at least 1 h at 55uC, then incubated with the
appropriate probe overnight at 55uC. Membranes were washed
thoroughly using the DIG Wash and Block kit, blocked for at least
1 h, and incubated with anti-DIG antibody for 30 min. Mem-
branes were then washed and treated with CDP-Star reagent to
detect DIG-incorporated bands. Blots were stripped and re-
probed according to the manufacturer’s instructions. Probe
sequences are provided in Table S2.
NanoString nCounter Assay
Total RNA was isolated from each iPSC clone between passage
10 and 15 using the RNeasy kit (Qiagen). A 100-ng sample of
RNA was then profiled using the NanoString nCounter system
(NanoString, Seattle, WA) using one of two custom-designed
codesets. The pluripotency codeset contains 25 probes for
detection of the Sendai and retroviral transgenes, pluripotency
and spontaneous differentiation markers, and housekeeping genes
Table S3. The lineage codeset is derived from a previous study
[15] and contains 85 probes for the three germ layers in addition
to probes for retroviral and Sendai transgenes, and housekeeping
genes Table S4. RNA from a retrovirus-positive or Sendai-
positive control line, a fibroblast line (1043), and two human ESC
lines (HUES42 and Hues16) was included in each run. Data were
analyzed using the nSolver Analysis Software v1.0 (NanoString)
and plotted using Prism (Graphpad Software, La Jolla, CA). Data
quality control and normalization to geometric mean for both
Figure 5. Stability of Fluorescence Activated Cell Sorted and Manually Derived IPSC Lines. Three individual clones were selected from
foreskin (0819) fibroblasts lines which previously underwent four factor retroviral reprogramming and were derived by either FACS (A, C1–C3) or
manual (B, C4–C6) techniques were analyzed by flow cytometry for pluripotent surface marker expression following expansion on murine embryonic
fibroblasts for 12–14 passages. Clones C3 and C6 were adapted to Matrigel and mTSER media around passage11 and expanded for several passages
prior to surface marker analysis by flow cytometry to demonstrate stability following changes in culture conditions. Events displayed in the 2D scatter
plots are ‘‘live’’ cells as defined by forward and side scatter properties expressing indicated surface markers.
doi:10.1371/journal.pone.0059867.g005
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internal positive controls, and subsequently for housekeeping
genes, was performed in the nSolver analysis software.
Embryoid Body Formation
Embryoid bodies (EB) were formed by placing clumps of iPSCs
in 96-well non-tissue culture treated V-bottom plates (Evergreen
222-8031-01V) containing HUESM. After 5 weeks of culture, EBs
Figure 6. Characterization of Fluorescence Activated Cell Sorted and Manually Derived IPSC Lines by Sendai virus.
Immunofluroescence microscopy of the 1001.131.01 line demonstrating expression of common markers of pluripotency by FACS or Manually
Derived IPSC lines. Nuclear Transcription Factors shown in Green, Surface Markers shown in Red, Nucleus stained with DAPI in Blue (A) Nanog/Tra-1-
60 (B) Oct4/Tra-1-81 (C) Sox2/SSEA4 (D) Oct4/Alkaline Phosphatase. 106 Magnification (E) Expression of endogenous pluripotent transcription
factors (F) Silencing of viral transcription factors occur by passage 5. (G) Expression levels of transcription factors common to the indicated germ
layers from EB generated by the indicated IPSC lines.
doi:10.1371/journal.pone.0059867.g006
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were harvested, fixed in 4% paraformaldehyde (PFA) for 30 min
at RT and processed in 15% and 30% sucrose solutions for one
day each prior embedding in O.C.T., freezing, sectioning into
10 mm slices and mounting on glass slides. EB sections were
immunostained with antibodies against the markers shown in
Table S5. Briefly, EB sections were incubated with blocking
solution 10% donkey serum in PBST (PBS with 0.1% Triton-100)
for 1 h at RT, followed by an overnight incubation at 4uC with
primary antibodies. After washing three times with PBST, sections
were incubated for 1 h at RT with appropriate secondary
antibodies obtained from Molecular Probes. Finally, sections were
washed and counterstained with DAPI (1:1000 in PBS) for 15 min
at RT.
Teratoma Assay
Manually (1023_C) and FACS-derived (1023_D2) cells were
dissociated using Dispase (Gibco 17105-041) for 15 minutes at
37uC to produce small clumps containing approximately 100–200
iPSCs/clump. The clumps were suspended in 100 ml of HUESM
containing 100 ml MatrigelTM (BD Biosciences) and injected
subcutaneously into NOD-SCID Il2rg-null mice (Jackson Labora-
tory) following an intraperitoneal injection of carprofen (Pfizer) at
5 mg/kg. Teratomas were allowed to grow for 6–8 weeks, isolated
by dissection and fixed in 4% PFA overnight at 4uC. Fixed tissues
were embedded in paraffin, sectioned at 10 mm and stained with
hematoxylin and eosin (H&E).
Results
FACS Derivation of iPSCs
Previous studies have demonstrated downregulation of the
human fibroblast marker CD13 [8], and upregulation of the
pluripotency markers SSEA4 and TRA-1-60 occurs during
reprogramming [9]. These studies suggest that isolation of fully
reprogrammed iPSCs during early stages of reprogramming may
be accomplished by FACS using a combination of positive and
negative surface markers. While current sorting strategies for
purification of pluripotent cells rely on positive selection [7], it is
possible that a significant proportion of clones isolated using this
method may not be fully reprogrammed. To test this hypothesis
we first optimized the conditions for survival of live-cell sorted,
fully reprogrammed cells by examining the expression levels of
three surface markers in a manually derived, early passage clone
(p4) of an iPSC line (1018) cultured on MEFs.
Populations of cells expressing all three markers were found in
the culture suggesting a heterogeneous mixture of cells containing
parental and partially reprogrammed fibroblasts Figure 1A. We
then sorted the CD13NEGSSEA4POSTra-1-60POS (Tra-1-60POS)
population and, as a control, the CD13NEGSSEA4POSTra-1-
60NEG (Tra-1-60NEG) population to approximately 70% purity
directly into one well of a 6 well plate containing MEFs in the
presence of ROCK inhibitor Y-27632. The sorted populations
were maintained for 20 days on MEFs without ROCK inhibitor or
removal of differentiated cells or splitting prior to reanalysis by
flow cytometry (FCM). At 20 days post-sorting (dps), the cultures
originating from the enriched Tra-1-60POS population contained
fewer Tra-1-60NEG differentiated cells and no detectable CD13POS
parental fibroblasts. The Tra-1-60POS population was present in
these cultures at approximately double the proportion found in the
Tra-1-60NEG enriched culture (30% vs. 14%). Conversely, at
20 dps the culture originating from the Tra-1-60NEG enriched
population contained a Tra-1-60POS population at a similar
proportion to the originally sorted culture (18%T vs. 14%T).
However, these cultures also contained a higher proportion of
differentiated or transformed cells (CD13NEGSSEA4NEGTra-1-
60NEG) as well as adult fibroblasts (CD13POS) suggesting that our
FACS conditions allow for purification of fully reprogrammed cells
from contaminating cell types.
To confirm this strategy, adult skin fibroblasts at 8 days post
infection (dpi) were sorted based on the CD13NEGSSEA4POSTra-
1-60POS surface marker profile. As a control, the CD13NEGS-
SEA4POS population that contained two subpopulations of cells
expressing either Tra-1-60POS or Tra-1-60NEG was isolated in
parallel. 5,000 or 10,000 cells from each population were sorted
directly into MEF-containing plates, and monitored for the
formation of colonies. Small but distinct colonies were evident in
both sorted populations as early as 3 days post sort (dps), with the
CD13NEGSSEA4POSTra-1-60POS population producing larger
and more abundant colonies than the CD13NEGSSEA4POS
population (3 dps, 11 dpi; Figure 1B). Following an additional
2 weeks of expansion without manual removal of differentiated
cells, wells containing the CD13NEGSSEA4POS population had
become overgrown with transformed and differentiated cells,
whereas wells containing the sorted CD13NEGSSEA4POSTra-1-
60POS cells contained large, well-separated colonies with few
differentiated cells between the colonies and lacked cells with
transformed morphology (17 dps, 25 dpi; Figure 1B). We
observed a 3–4 fold increase in the number of colonies present
in wells containing the sorted CD13NEGSSEA4POSTra-1-60POS
cells compared to the sorted CD13NEGSSEA4POS cells Figure 1C.
We then analyzed CD13 expression within the SSEA4POSTra-
1-60POS population of reprogrammed fibroblasts at 7 dpi.
Roughly one quarter of the SSEA4POSTra-1-60POS population
expressed CD13 indicating the presence of a heterogeneous
population of fully reprogrammed, transformed, or transitioning
cells (23% CD13POS, 66% CD132; Figure 1D), some of which
expressed both Nanog and CD13 Figure 1E.
Because surface marker expression during reprogramming is
dynamic, we wanted to first identify the earliest time point at
which to enrich fully reprogrammed iPSCs. Time course analysis
conducted by flow cytometry following retroviral reprograming
suggested that SSEA4POSTra-1-60POS cells were detectable as
early as 7 dpi, and their proportion increased up to 21 dpi, then
remained constant as marker negative cells outgrew the repro-
grammed cells Figure S1. The SSEA4POSTra-1-60POS popula-
tion also expressed the SSEA3 and CD326 pluripotency markers
[16,17,18,19]. SSEA4POSCD13POS cells appeared by 7 dpi and
while most of this population disappeared by 14 dpi, a proportion
remained in the culture. To test whether this timing was consistent
among different skin samples, we analyzed cultures derived from a
foreskin fibroblast line (0825), a healthy adult control fibroblast
line (1023), and a fibroblast line from a subject with type I diabetes
(1018) for up to 21 dpi. The three fibroblast cell lines showed a
consistent emergence of pluripotent surface markers with SSEA4-
POSTra-1-60POS cells present at low numbers at 7 dpi (D7, 0.3%–
0.4% Figure 2A), increasing in proportion at 14 dpi (D14, 1.4%–
2.2%), and decreasing by day 21 as other cells overtook the culture
(D21, 0.7%), suggesting a consistent appearance of potentially early
reprogrammed cells between 7 and 14 dpi. However, at early time
points, the majority of SSEA4POSTra-1-60POS cells also expressed
CD13 (D7, 98%–100%). The proportion of CD13
POSSSEA4POS-
Tra-1-60POS decreased approximately half by day 14 post
infection (D14, 37%–54%), suggesting loss of this fibroblast marker
on cells undergoing reprogramming. Interestingly, the CD13POSS-
SEA4POSTra-1-60POS population increased again by day 21,
suggesting that this population was expanding or that CD13NEG
cells were lost from the culture.
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Based on these results we developed the sorting strategy shown
in Figure 2B which omits the contaminating partially repro-
grammed CD13POSSSEA4POS population by selecting the highest
Tra-1-60POS expressing cells within the CD13NEGSSEA4POS
population. Using this strategy we FACS derived 228 individual
iPSC lines from over 75 fresh or frozen fibroblast lines generated
from biopsies harvested from healthy or disease patients using
either integrating (retroviral) or non-integrating (Sendai virus)
reprogramming vectors and performed extensive characterization
on a subset of those lines which is described in the data that
follows. We further characterized the first 2 weeks of the
reprogramming process on 128 FACS derived iPSC lines using
the analysis structure shown in Figure 1D. As shown in
Figure 2C, a higher percentage of SSEA4POSTra-1-60POS cells
were generated in Sendai infections compared to retroviral
infections over the entire time course. However, Sendai infections
demonstrated a delayed reduction in the proportion of
CD13POSSSEA4POSTra-1-60POS cells Figure 2D. By the second
week of induction, the proportion of the CD13POS population
between the cultures was similar.
FACS Derived Lines are Pluripotent
To further characterize this defined selection strategy, we
compared the phenotype and function of the FACS-derived iPSC
clones to manually picked clones. First, the 0825, 1018, and 1023
fibroblast lines shown in Figure 2A reprogrammed using the 4-
factor retroviral protocol were subjected to either FACS derivation
at 7 dpi or standard picking techniques. For each method, one
clone from each line was randomly selected for expansion and
further characterization by a standard battery of assays, including
karyotypic analysis, DNA fingerprint, pluripotent surface marker
expression, qRT-PCR, and Embryoid body (EB) and teratoma
formation. All fibroblasts and reprogrammed iPSC lines displayed
normal karyotypes, and had DNA fingerprints matching the
parental fibroblast line Figure S2. Clones from the 0825 foreskin
fibroblast line had a DNA fingerprint that matched a major
subpopulation in the parental fibroblasts that contained a
contaminating subpopulation with a different genotype, suggesting
isolation of clonal cultures from a mixed population.
Both the manually and FACS-derived iPSC lines expressed
common markers of pluripotency, including the surface marker
Tra-1-60 and the transcription factor Nanog, and generated
compact colonies morphologically consistent with normal hESCs,
Figure S3 (A–B). Next, the cell lines were expanded for ten
passages and the expression of endogenous Nanog, Oct4, Sox2,
cMyc, and Klf4, and silencing of the viral transgenes Oct4, Sox2,
Klf4, and cMyc were assayed. We used a probe-based Nanostring
nCounter transcript quantification assay, to assess pluripotency by
detecting both activation of endogenous gene expression
Figure 3A and silencing of retroviral transgenes Figure 3B.
These data were further confirmed by qPCR Figure S3 and
revealed a similar pattern of endogenous gene expression in all
iPSC lines compared to undifferentiated hESC controls
Figure 3A, Figure S3. However, two of the three manually
derived clones (1018_2 and 1023_C) maintained much higher
expression of the viral transgenes than the sorted clones
Figure 3B. Additionally, the 1018_2 cultures expressed CD13,
indicating the presence of non-reprogrammed or partially
transformed human fibroblasts in the manually picked lines
Figure 3B. These analyses suggest that selection of single cells
based on CD13NEGSSEA4POSTra-1-60POS expression can be used
to select against partially reprogrammed or contaminating cell
types in reprogrammed cultures. The full data set for these
experiments is provided in Table S7.
We next examined undirected EB formation to measure the
in vitro differentiation potential of FACS and manually-derived
iPSCs clones. Following differentiation for 5 weeks, EBs were
collected and assayed for markers of three embryonic germ layers
endoderm, mesoderm, and ectoderm by immunohistochemistry
for a1-fetoprotein (AFP), smooth muscle actin (aSMA), and beta
III tubulin (Tuj1), respectively. EBs derived from FACS or
manually picked clones expressed markers associated with
formation of the three germ layers Figure 4A–B. To further
define the differentiation potential of the derived lines, RNA from
the EBs were collected after two weeks of differentiation and tested
against a panel of lineage-specific nCounter probes Table S4
previously validated to detect expression of genes commonly found
in the three germ layers [15] Figure 4C. With the exception of
the FACS-derived 0825 line, all lines expressed comparable levels
of the germ layer-associated genes, indicating they have similar
potential to spontaneously differentiate in vitro into any germ layer.
The full data set for these experiments is provided in Table S8.
To measure the in vivo differentiation potential of the iPSCs,
immunocompromized mice were injected with FACS or manually
derived clones from the 1023 fibroblast line. The resulting
teratomas were sectioned and examined by H&E staining. This
analysis showed that teratomas generated from sorted Figure 4D
or manually derived Figure 4E clones formed all three germ layer
tissues, including gut-like epithelial tissues (endoderm), cartilage
(mesoderm), and retinal pigment epithelium (ectoderm). Together,
these analyses validate the use of CD13NEGSSEA4POSTra-1-
60POS expression as a surface marker signature compatible with
FACS that can be used to isolate a population of fully
reprogrammed iPSCs.
FACS Derivation Produces Independent Clones
Because iPSC lines can arise from rare apparently stochastic
events at early time points during reprogramming, it was
important to establish that FACS sorting could isolate multiple
independent reprogramming events. To determine whether FACS
derivation can produce unique cell lines in a similar manner to
manual picking, we performed Southern blotting on several clones
derived by both methods. Klf4 and Oct4 probes were used to
identify the endogenous and virally integrated forms of the genes.
Different banding patterns indicate differences in the chromo-
somal integration sites and, in some cases, varying numbers of
detectable integration events. As shown in Figure 3C, all three
sorted clones from line 1023 have different integration sites for
both Klf4 and Oct4, demonstrating they are independent clones.
In contrast, two of the three picked clones from line 1023 have
identical banding patterns for Klf4 and Oct4, suggesting they are
the same clone. Of the iPSC lines generated from three different
fibroblast lines, 8/9 FACS-derived lines were independent clones,
while 7/9 manually picked lines were independent (data not
shown), suggesting equivalent ability to generate clonal cultures.
Therefore, FACS sorting between 7–14 dpi using of CD13NEGS-
SEA4POSTra-1-60POS can generate independent clonal cultures
following retroviral reprogramming.
FACS Derived Lines are Stable at Later Passages
To demonstrate the stability of FACS derived ips clones at later
passages, we retrovirally reprogrammed a foreskin fibroblast line
(0819) using both FACS and manual derivation methods. Three
individual clones were chosen from each derivation method and
expanded on MEFs to asses pluripotent surface marker expression
by FCM at later passages. As shown in the first row of Figure 5A–
B, cultures of all clones (C1–C6) resulting from each derivation
method possessed populations of cells positively expressing both
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SSEA4 and Tra-1-60 at varying proportions indicating stability at
between 12–14 passages. Although not shown in Figure 5,
cultures of these clones were stable at earlier (p4–p11) and later
(p20–p25) passages. Clones C3 and C6 were adapted to matrigel
and mTser media (*C3 and *C6 in Fig. 5A,B) following 11 passages
on MEFS and expanded for 3–5 passages to demonstrate the
stability of FACS derived ips lines following changes in substrate
and media conditions. FCM analysis of Matrigel adapted ips lines
show stable surface marker expression with less SSEA4POSTra-1-
60NEG populations than the manually derived clone C6. Small
populations of CD13POS expressing both Tra-1-60POS and Tra-1-
60NEG (second row of Figure 5A–B) were present in all cultures
with the exception of the FACS derived C3 and *C3 clones
indicating the variability present in individual clones derived
under DNA integrating reprogramming techniques. Similar results
are observed within clones derived using the non-integrating
Sendai viral platform (Data not shown). These results demonstrate
that FACS derived ips clones remain stable over multiple passages
and following adaptation to feeder free conditions.
Utility for Multiple Reprogramming Methods
To further validate that the FACS surface marker panel can be
used for multiple reprogramming methods, we reprogrammed
fibroblasts using non-integrating Sendai viral constructs carrying
the four Yamanaka reprogramming factors and compared the
FACS and manual derivation methods to determine if there were
differences between the integrating and non-integrating repro-
gramming systems. For these studies, an adult fibroblast line (131)
was infected and subjected to either FACS sorting at 11 dpi or to
manual derivation. At 11 dpi, the fraction of SSEA4POSTRA-1-
60POS cells that were also CD13POS was significantly lower (1–2%,
data not shown) than with retroviral reprogramming (37–54%,
Figure 2C), suggesting an accelerated rate of reprogramming. As
before with the retroviral lines, several clones from each derivation
technique were selected and expanded for characterization
following confirmation that the parent fibroblast line possessed a
normal karyotype and DNA fingerprint, and was free of
contaminating cell lines Figure S2.
As before, individual clones selected from both FACS and
manual derivation techniques expressed the common markers of
pluripotency, as revealed by immunostaining Figure 6A–D. In
addition, the sorted (SRT) and picked (PCK) clones showed
comparable levels of endogenous Oct4, Sox2, KLF4, MYC, and
Nanog gene expression as early as passage 5, which remained
relatively constant to passage 10, Figure 6E. Similarly, though
greatly reduced compared to control infected fibroblasts, Sendai
virus gene expression was slightly above background at passage 5
in one sorted and one picked clone. However, this Sendai gene
expression was eliminated by passage 10 in both cases, Figure 6F.
The full data set for these experiments is provided in Table S9.
The in vitro differentiation potential of FACS and manually
derived iPSC clones reprogrammed by the Sendai virus protocol
was evaluated by EB formation and a lineage specific nCounter
assay as above. Similar trends in gene expression were observed
for clones derived under both methods, Figure 6G. Both sorted
and picked lines expressed levels of the ectodermal marker FGFR2
comparable to that of the control HUES42 line but higher levels of
the mesodermal marker HHEX. Most clones showed levels of
endodermal gene expression comparable to the HUES42 line with
the exception of a manually derived clone that expressed higher
levels of GATA6 than the remaining picked lines or FACS-derived
lines. The full data set for these experiments is provided in Table
S10. Collectively, these data demonstrate that using FACS to
purify the CD13NEGSSEA4POSTra-1-60POS cells from either
retroviral or Sendai viral 4-factor reprogramming protocols
consistently produces high quality iPSC lines.
Discussion
Clinical application of iPSC technology will require standard-
ized and reproducible methods for each step of derivation and
differentiation into relevant cell types. We have found that the
majority of manually derived iPSC lines contain CD13POS cells
even after prolonged culture suggesting that these lines were either
not fully reprogrammed or that CD13POS cells were carried over
during passage. While both manual picking and FACS sorting
methods [10] have been used to isolate reprogrammed pluripotent
cells, we demonstrated that inclusion of a negative selection
marker such as CD13 has significant advantages in improving the
purity of reprogrammed cultures. This fact was previously
demonstrated [13]. Here, we have validated a surface marker
profile that enables selection of early reprogrammed iPSCs
following reprogramming with either DNA-integrating or non-
integrating viruses by FACS. Employing this strategy as early as
7 dpi isolates a highly purified starting population of fully
functional CD13NEGSSEA4POSTra-1-60POS cells that are depleted
of contaminating non-transduced and transformed fibroblasts. We
have successfully generated and characterized 228 individual iPSC
lines in 2 years from 76 fibroblast lines obtained from fresh
biopsies, frozen stocks, and cell line repositories harvested from
healthy and individuals possessing various forms of diabetes,
neurodegenerative, cardiac and autoimmune diseases. Table S6.
Moreover, we routinely use FACS for maintenance of
established cell lines to remove differentiated cells and to dispense
graded numbers of highly purified CD13NEGSSEA4POSTra-1-
60POS populations cells for use in high-throughput derivation and
screening assays which include directed differentiation and
automated drug screening and phenotyping experiments. This is
an important property because the results of these assays could be
unequivocally attributed to a defined population of reprogrammed
cells rather than to a heterogeneous mixture of cells. Taken
together, these results suggest that isolation of the CD13NEGS-
SEA4POSTra-1-60POS population following reprogramming, in-
cluding integrating or non-integrating viral technologies, allows for
the rapid isolation of high quality iPSC lines. Negative selection
against CD13POS cells significantly reduces the appearance of
transformed cells in ipsc cultures and suggests that negative
selection for a marker present on the starting somatic cells can be
used to exclude non-reprogrammed or transformed cells from the
cultures. Future studies will be needed to determine if this strategy
applies to derivation from other somatic cell types or reprogram-
ming methods.
Supporting Information
Figure S1 Time Course analysis of retroviral repro-
grammed fibroblasts. The 0825 foreskin fibroblast line was
analyzed for changes in pluripotent surface marker expression by
flow cytometry at ,7 dpi intervals following retroviral repro-
gramming to determine earliest time point at which the
CD13NEGSSEA4POSTra-1-60POS population appears. Values
indicate percent of total cells in the culture expressing the
indicated markers.
(TIF)
Figure S2 Karyotype of FACS and Manually Derived
retroviral iPS lines possess a normal karyotype and match
the parent fibroblast. Karyotype was assessed using 20 G-banded
metaphase cells from each fibroblast and reprogrammed lines at
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passages indicated. All lines possess a normal karyotype and match the
parent fibroblast. Karyotype was assessed using 20 G-banded
metaphase cells from each fibroblast and reprogrammed lines at
passages indicated. Fibroblasts and FACS derived lines possess a
normal karyotype and match the parent fibroblast. Three out of 20
cells from the manually derived line displayed an unbalanced
translocation between the short arm of chromosomes 11 and 22
resulting in trisomy of the short arm of chromosome 11.
(TIF)
Figure S3 FACS and Manually Derived Sendai iPS lines
express pluripotency markers. FACS (A) or Manually (B)
derived clones were expanded on MEF feeder layers and stained
for two common markers of pluripotency: Tra-1-60 and Nanog.
106 Magnification. All lines show consistent expression of
pluripotency markers. (C) qRTPCR showing expression of
endogenous gene expression and silencing (D) of retroviral genes.
(TIF)
Table S1 Quantitative real-time PCR Primers.
(DOC)
Table S2 Southern Blot Primers.
(DOC)
Table S3 NanoString Pluripotency Codeset.
(DOC)
Table S4 NanoString Lineage Codeset.
(DOC)
Table S5 Primary Antibodies for Immunofluorescence.
(DOC)
Table S6 Summary of FACS Derived hIPSC Lines.
(DOC)
Table S7 Full Nanostring Data Set For Pluripotent Gene
Expresion of Retrovirally Reproggrammed Fibroblasts.
(XLSX)
Table S8 Full Nanostring Data Set For Embryoid Bodies
Derived From Retrovirally Reproggrammed Fibro-
blasts.
(XLSX)
Table S9 Full Nanostring Data Set For Pluripotent Gene
Expresion of Sendai Reproggrammed Fibroblasts.
(XLSX)
Table S10 Full Nanostring Data Set For Embryoid
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